Package 51991-898-30

Brand: rivastigmine transdermal system

Generic: rivastigmine
NDC Package

Package Facts

Identity

Package NDC 51991-898-30
Digits Only 5199189830
Product NDC 51991-898
Product ID 51991-898_6c0c606b-108e-4837-8533-f485f9e4ee4b
Description

30 POUCH in 1 CARTON (51991-898-30) / 1 PATCH in 1 POUCH (51991-898-99) / 24 h in 1 PATCH

Marketing

Marketing Status
Marketed Since 2019-12-19
Brand rivastigmine transdermal system
Generic rivastigmine
Sample Package No

Linked Drug Pages (1)

Rivastigmine Transdermal System ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TRANSDERMAL"], "spl_id": "6c0c606b-108e-4837-8533-f485f9e4ee4b", "openfda": {"nui": ["N0000175723", "N0000000177"], "upc": ["0351991899303"], "unii": ["PKI06M3IW0"], "rxcui": ["725021", "725023", "1308569"], "spl_set_id": ["b201fe68-b5e5-4a6f-8cf1-069543f03e76"], "pharm_class_epc": ["Cholinesterase Inhibitor [EPC]"], "pharm_class_moa": ["Cholinesterase Inhibitors [MoA]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (51991-898-30)  / 1 PATCH in 1 POUCH (51991-898-99)  / 24 h in 1 PATCH", "package_ndc": "51991-898-30", "marketing_start_date": "20191219"}], "brand_name": "Rivastigmine Transdermal System", "product_id": "51991-898_6c0c606b-108e-4837-8533-f485f9e4ee4b", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "51991-898", "generic_name": "Rivastigmine", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Transdermal System", "active_ingredients": [{"name": "RIVASTIGMINE", "strength": "9.5 mg/24h"}], "application_number": "ANDA209063", "marketing_category": "ANDA", "marketing_start_date": "20191219", "listing_expiration_date": "20261231"}